{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:16:38Z","timestamp":1793319398515,"version":"4.5.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["2025-PUMCH-C-029"],"award-info":[{"award-number":["2025-PUMCH-C-029"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2023-I2M-C"],"award-info":[{"award-number":["2023-I2M-C"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["T-B-037"],"award-info":[{"award-number":["T-B-037"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbcan.2026.189581","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:04:21Z","timestamp":1775099061000},"page":"189581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor immune microenvironment in cervical cancer: Histological subtype-specific immune landscapes and therapeutic implications"],"prefix":"10.1016","volume":"1881","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2026.189581_bb0010","article-title":"Survival comparison between squamous cell carcinoma and adenocarcinoma for radiotherapy-treated patients with stage IIB-IVA cervical cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12885-022-09401-x","article-title":"Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma\/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0020","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e80","article-title":"Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis","volume":"31","author":"Pan","year":"2020","journal-title":"J. Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/01.pas.0000213434.91868.b0","article-title":"Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix","volume":"31","author":"Kojima","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12935-022-02716-6","article-title":"The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes","volume":"22","author":"Sun","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ijgc-2021-003159","article-title":"Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis","volume":"32","author":"Li","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","article-title":"Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189581_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111201","article-title":"Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment","volume":"40","author":"Papadas","year":"2022","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189581_bb0050","article-title":"Single-cell landscape highlights heterogenous microenvironment, novel immune reaction patterns, potential biomarkers and unique therapeutic strategies of cervical squamous carcinoma, human papillomavirus-associated (HPVA) and non-HPVA adenocarcinoma","volume":"10","author":"Qiu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189581_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338230","article-title":"CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer","volume":"6","author":"Komdeur","year":"2017","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189581_bb0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","article-title":"Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer","volume":"20","author":"Webb","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1936391","article-title":"Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer","volume":"10","author":"Kol","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189581_bb0070","article-title":"STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41418-023-01242-w","article-title":"Activating STING\/TBK1 suppresses tumor growth via degrading HPV16\/18 E7 oncoproteins in cervical cancer","volume":"31","author":"Huang","year":"2024","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008355","article-title":"Multiomics profiling reveals the benefits of gamma-delta (\u03b3\u03b4) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer","volume":"12","author":"Li","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189581_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2019.12.038","article-title":"Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240\/microRNA-124-3p\/STAT3\/MICA axis","volume":"474","author":"Zhang","year":"2020","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189581_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/07357907.2014.883526","article-title":"IL-2 enhances cervical cancer cells proliferation and JAK3\/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects","volume":"32","author":"Valle-Mendiola","year":"2014","journal-title":"Cancer Investig."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189581_bb0095","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/cac2.12486","volume":"43","author":"Qu","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189581_bb0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8(+) T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"29","key":"10.1016\/j.bbcan.2026.189581_bb0105","article-title":"Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma","volume":"9","author":"Ou","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189581_bb0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41416-020-01184-x","article-title":"Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis","volume":"124","author":"Litwin","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17102-w","article-title":"Oestrogen receptor-\u03b1 binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer","volume":"7","author":"Adurthi","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12985-025-02664-3","article-title":"Prognostic assessment of cervical cancer based on biomarkers: the interaction of ERR\u03b1 and immune microenvironment","volume":"22","author":"Zheng","year":"2025","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0125","first-page":"6215","article-title":"Th17 response in patients with cervical cancer","volume":"16","author":"Alves","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189581_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/314620","article-title":"Th17 cell plasticity and functions in cancer immunity","volume":"2015","author":"Gu\u00e9ry","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0135","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.984539","article-title":"Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer","volume":"4","author":"Punt","year":"2015","journal-title":"Oncoimmunology"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189581_bb0140","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110757","article-title":"Single-cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment","volume":"42","author":"Cao","year":"2023","journal-title":"EMBO J."},{"issue":"25","key":"10.1016\/j.bbcan.2026.189581_bb0145","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003667","article-title":"Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer","volume":"10","author":"Wang","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0155","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202000528RR","article-title":"The role of Tim-3\/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma","volume":"35","author":"Chen","year":"2021","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000911","article-title":"Tim-3 finds its place in the cancer immunotherapy landscape","volume":"8","author":"Acharya","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12967-022-03480-x","article-title":"Blocking TIGIT\/CD155 signalling reverses CD8(+) T cell exhaustion and enhances the antitumor activity in cervical cancer","volume":"20","author":"Liu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"105","key":"10.1016\/j.bbcan.2026.189581_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado3032","article-title":"Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate","volume":"10","author":"Huang","year":"2025","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0175","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.bbcan.2026.189581_bb0180","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.7150\/thno.59605","article-title":"PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189581_bb0185","first-page":"6898","article-title":"Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma","volume":"16","author":"Xiong","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0190","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1186\/s12885-023-11426-9","article-title":"Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0195","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2007.08.089","article-title":"A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years","volume":"108","author":"Nedergaard","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s42003-020-0964-7","article-title":"Omics-wide quantitative B-cell infiltration analyses identify GPR18 for human cancer prognosis with superiority over CD20","volume":"3","author":"Liu","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6519427","article-title":"Role of regulatory B cells in the progression of cervical cancer","volume":"2019","author":"Chen","year":"2019","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0210","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ijc.30169","article-title":"B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer","volume":"139","author":"Tang","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189581_bb0215","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/ijc.23733","article-title":"Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer","volume":"123","author":"Textor","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189581_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104846","article-title":"Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma","volume":"97","author":"Lin","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28857","article-title":"Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing","volume":"95","author":"Li","year":"2023","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0230","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/cas.13476","article-title":"Tumor-associated CD204(+) M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma","volume":"109","author":"Kawachi","year":"2018","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2022.10.003","article-title":"Gastric-type adenocarcinoma of the cervix: clinical outcomes and genomic drivers","volume":"167","author":"Ehmann","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0240","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41416-023-02555-w","article-title":"Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers","volume":"130","author":"Wang","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0245","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41379-020-00726-1","article-title":"Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations","volume":"34","author":"Selenica","year":"2021","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13000-025-01666-7","article-title":"Clinical pathological and molecular features of 100 patients with gastric-type cervical adenocarcinoma","volume":"20","author":"Gao","year":"2025","journal-title":"Diagn. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0255","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4274\/tjod.galenos.2023.62819","article-title":"Clear cell carcinoma of the uterine cervix; an unusual HPV-independent tumor: clinicopathological features, PD-L1 expression, and mismatch repair protein deficiency status of 16 cases","volume":"20","author":"Bulutay","year":"2023","journal-title":"Turk. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0260","article-title":"Complete response to PD-1 inhibition in an adolescent with relapsed clear cell adenocarcinoma of the cervix predicted by neoepitope burden and APOBEC signature","volume":"4","author":"Levinson","year":"2020","journal-title":"JCO Precis. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189581_bb0265","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.21037\/tcr.2020.03.35","article-title":"Glassy cell carcinoma of cervix: an analysis for 20 cases and literatures review","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189581_bb0270","first-page":"1842","article-title":"Glassy cell carcinoma of the uterine cervix: a rare entity and literature review","volume":"19","author":"Richard","year":"2025","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0275","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/path.6290","article-title":"Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix","volume":"263","author":"Pan","year":"2024","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189581_bb0280","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41588-023-01570-0","article-title":"Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance","volume":"55","author":"Fan","year":"2023","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189581_bb0285","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3892\/ijmm.2016.2845","article-title":"ISG15 inhibits cancer cell growth and promotes apoptosis","volume":"39","author":"Zhou","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28410","article-title":"Single-cell transcriptomic analysis of the role of HPV16-positive macrophages in cervical cancer prognosis","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0295","article-title":"Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"7645","key":"10.1016\/j.bbcan.2026.189581_bb0300","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12964-023-01450-4","article-title":"Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRP\u03b1 axis","volume":"22","author":"Chen","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2026.189581_bb0310","article-title":"Multi-omics analysis showed the clinical value of gene signatures of C1QC(+) and SPP1(+) TAMs in cervical cancer","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189581_bb0315","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1158\/1078-0432.CCR-19-3826","article-title":"Adenocarcinoma of the uterine cervix shows impaired recruitment of cDC1 and CD8(+) T cells and elevated \u03b2-catenin activation compared with squamous cell carcinoma","volume":"26","author":"Rotman","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s42003-025-07605-y","article-title":"Single-cell RNA sequencing reveals tumor heterogeneity in small cell neuroendocrine cervical carcinoma","volume":"8","author":"Xiang","year":"2025","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189581_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25116205","article-title":"Unraveling differences in molecular mechanisms and immunological contrasts between squamous cell carcinoma and adenocarcinoma of the cervix","volume":"25","author":"Salarzaei","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0330","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.1996.4579","article-title":"Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix","volume":"64","author":"Santin","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189581_bb0335","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s13577-023-00882-x","article-title":"Insights into the characteristics of primary radioresistant cervical cancer using single-cell transcriptomics","volume":"36","author":"Xing","year":"2023","journal-title":"Hum. Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189581_bb0340","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cell.2014.03.006","article-title":"The fire within: microbes inflame tumors","volume":"157","author":"Gagliani","year":"2014","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.bbcan.2026.189581_bb0345","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1158\/0008-5472.CAN-15-0732","article-title":"Stromal fibroblasts induce CCL20 through IL6\/C\/EBP\u03b2 to support the recruitment of Th17 cells during cervical cancer progression","volume":"75","author":"Walch-R\u00fcckheim","year":"2015","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189581_bb0350","article-title":"The role of chemokines in cervical cancers","volume":"57","author":"Garrido","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189581_bb0355","first-page":"3698","article-title":"Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice","volume":"59","author":"Tartour","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189581_bb0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-015-0350-0","article-title":"Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer","volume":"14","author":"Punt","year":"2015","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.bbcan.2026.189581_bb0365","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-24-0385","article-title":"Cervical cancer evades the host immune system through the inhibition of type I interferon and CXCL9 by LIF","volume":"30","author":"Bonfill-Teixidor","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189581_bb0370","article-title":"Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0375","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/CJI.0b013e31803240fa","article-title":"Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer","volume":"30","author":"Zehbe","year":"2007","journal-title":"J. Immunother."},{"key":"10.1016\/j.bbcan.2026.189581_bb0380","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.97335","article-title":"Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma","volume":"13","author":"Peng","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.bbcan.2026.189581_bb0385","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19072","article-title":"TGF-\u03b2-mediated activation of fibroblasts in cervical cancer: implications for tumor microenvironment and prognosis","volume":"13","author":"Qu","year":"2025","journal-title":"PeerJ"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189581_bb0390","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.7150\/jca.22532","article-title":"PD-L1 expression correlates with tumor infiltrating lymphocytes and response to neoadjuvant chemotherapy in cervical cancer","volume":"9","author":"Meng","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189581_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.678758","article-title":"PD-1 expression status on CD8+ tumour infiltrating lymphocytes associates with survival in cervical cancer","volume":"11","author":"Fan","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152782","article-title":"The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix","volume":"216","author":"Karpathiou","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbcan.2026.189581_bb0405","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231208846","article-title":"Research progress of immuno-inhibitory receptors in gynecological cervical cancer","volume":"22","author":"Li","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0410","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1470-2045(24)00088-3","article-title":"Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial","volume":"25","author":"Oaknin","year":"2024","journal-title":"Lancet Oncol."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189581_bb0415","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0420","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa2112187","article-title":"Survival with cemiplimab in recurrent cervical cancer","volume":"386","author":"Tewari","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189581_bb0425","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jamaoncol.2023.5410","article-title":"Pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer: subgroup analyses from the KEYNOTE-826 randomized clinical trial","volume":"10","author":"Tewari","year":"2024","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0430","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.annonc.2024.10.002","article-title":"Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study","volume":"36","author":"Lorusso","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0435","article-title":"The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189581_bb0440","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3776","article-title":"Association of ipilimumab with safety and antitumor activity in women with metastatic or recurrent human papillomavirus-related cervical carcinoma","volume":"4","author":"Lheureux","year":"2018","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189581_bb0445","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.21.02067","article-title":"Dual PD-1 and CTLA-4 checkpoint blockade using balstilimab and zalifrelimab combination as second-line treatment for advanced cervical cancer: an open-label phase II study","volume":"40","author":"O\u2019Malley","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"10463","key":"10.1016\/j.bbcan.2026.189581_bb0450","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(24)02135-4","article-title":"Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China","volume":"404","author":"Wu","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189581_bb0455","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ijc.32785","article-title":"Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival","volume":"147","author":"Tu","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189581_bb0460","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.cell.2024.07.018","article-title":"LAG-3 sustains TOX expression and regulates the CD94\/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity","volume":"187","author":"Ngiow","year":"2024","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0465","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41379-019-0433-3","article-title":"Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia","volume":"33","author":"Curley","year":"2020","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189581_bb0470","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189581_bb0475","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41419-020-03042-3","article-title":"Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0480","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13000-017-0631-6","article-title":"Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas","volume":"12","author":"Reddy","year":"2017","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0485","first-page":"568","article-title":"Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189581_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157469","article-title":"A comparative analysis of usual- and gastric-type cervical adenocarcinoma in a Japanese population reveals distinct clinicopathological and molecular features with prognostic and therapeutic insights","volume":"26","author":"Zahan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189581_bb0495","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3892\/mco.2025.2841","article-title":"Immunotherapy benefits PD-L1-positive gastric-type endocervical adenocarcinoma: a multicenter, retrospective study","volume":"22","author":"Li","year":"2025","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/cjp2.345","article-title":"Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance","volume":"10","author":"Sun","year":"2024","journal-title":"J. Pathol. Clin. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0505","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s44178-024-00120-w","article-title":"Advances in management algorithm in clear cell carcinoma of cervix","volume":"3","author":"Peng","year":"2024","journal-title":"Holist. Integr. Oncol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0510","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1283632","article-title":"Expression and significance of immune checkpoints in clear cell carcinoma of the uterine cervix","volume":"2020","author":"Zong","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189581_bb0515","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00404-021-06164-x","article-title":"Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints","volume":"305","author":"Blake","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14050462","article-title":"Advancements in the understanding of small-cell neuroendocrine cervical cancer: where we stand and what lies ahead","volume":"14","author":"Wang","year":"2024","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0525","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189581_bb0530","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.clinbiochem.2016.04.008","article-title":"Analysis of kynurenine\/tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients","volume":"49","author":"Hascitha","year":"2016","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189581_bb0535","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncy.22172","article-title":"Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer","volume":"127","author":"Venancio","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0540","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3389\/fimmu.2018.01598","article-title":"Indoleamine 2,3-dioxygenase expression pattern in the tumor microenvironment predicts clinical outcome in early stage cervical cancer","volume":"9","author":"Heeren","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189581_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082280","article-title":"Combined inhibition of indolamine-2,3-dioxygenase 1 and C-X-C chemokine receptor type 2 exerts antitumor effects in a preclinical model of cervical cancer","volume":"11","author":"Lizcano-Meneses","year":"2023","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189581_bb0550","first-page":"3777","article-title":"Role of hypoxia in inhibiting dendritic cells by VEGF signaling in tumor microenvironments: mechanism and application","volume":"11","author":"Han","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189581_bb0555","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10456-022-09863-4","article-title":"Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy","volume":"26","author":"Nowak-Sliwinska","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbcan.2026.189581_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1291530","article-title":"Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy","volume":"14","author":"Qian","year":"2023","journal-title":"Front. Immunol."},{"issue":"10103","key":"10.1016\/j.bbcan.2026.189581_bb0565","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(17)31607-0","article-title":"Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (gynecologic oncology group 240)","volume":"390","author":"Tewari","year":"2017","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189581_bb0570","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.bbcan.2026.189581_bb0575","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1200\/JCO.23.00914","article-title":"First-line pembrolizumab + chemotherapy versus placebo + chemotherapy for persistent, recurrent, or metastatic cervical cancer: final overall survival results of KEYNOTE-826","volume":"41","author":"Monk","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"10421","key":"10.1016\/j.bbcan.2026.189581_bb0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(23)02405-4","article-title":"Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial","volume":"403","author":"Oaknin","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0585","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189581_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.753386","article-title":"Single-cell RNA sequencing reveals multiple pathways and the tumor microenvironment could lead to chemotherapy resistance in cervical cancer","volume":"11","author":"Gu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0595","article-title":"Recent advances of anti-angiogenic inhibitors targeting VEGF\/VEGFR axis","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189581_bb0600","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41419-024-07128-0","article-title":"YTHDF1 boosts the lactate accumulation to potentiate cervical cancer cells immune escape","volume":"15","author":"Xiong","year":"2024","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189581_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911943","article-title":"Lactate-lactylation hands between metabolic reprogramming and immunosuppression","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"32","key":"10.1016\/j.bbcan.2026.189581_bb0610","article-title":"NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0615","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/JLB.3A0718-274RR","article-title":"Lactate secreted by cervical cancer cells modulates macrophage phenotype","volume":"105","author":"Stone","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189581_bb0620","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","article-title":"Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring","volume":"41","author":"Colbert","year":"2023","journal-title":"Cancer Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2026.189581_bb0625","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61942-2","article-title":"Compositional and functional differences of the vaginal microbiota of women with and without cervical dysplasia","volume":"14","author":"Norenhag","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0635","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12879-025-10851-4","article-title":"Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis","volume":"25","author":"Peng","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbcan.2026.189581_bb0640","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41698-020-0126-x","article-title":"Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment","volume":"4","author":"\u0141aniewski","year":"2020","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0645","doi-asserted-by":"crossref","DOI":"10.1177\/11795549251380470","article-title":"The role of the vaginal microbiome in immune modulation in cervical cancer: composition, molecular mechanisms, and therapeutic potential","volume":"19","author":"Chen","year":"2025","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0650","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2147\/IJWH.S406596","article-title":"Imbalance of vaginal microbiota and immunity: two main accomplices of cervical cancer in Chinese women","volume":"15","author":"Li","year":"2023","journal-title":"Int. J. Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0655","article-title":"Leveraging existing 16S rRNA gene surveys to decipher microbial signatures and dysbiosis in cervical carcinogenesis","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189581_bb0660","first-page":"23337","article-title":"Intratumoral levels and prognostic significance of Fusobacterium nucleatum in cervical carcinoma","volume":"12","author":"Huang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0665","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s42003-022-03681-6","article-title":"Immunometabolic and potential tumor-promoting changes in 3D cervical cell models infected with bacterial vaginosis-associated bacteria","volume":"5","author":"Maarsingh","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1110001","article-title":"Female reproductive tract-organ axes","volume":"14","author":"Takada","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0675","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s42003-021-01741-x","article-title":"Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation","volume":"4","author":"Sims","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109449","article-title":"Human papillomavirus 16 E6\/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p\/PD-L1 axis","volume":"731","author":"Ling","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbcan.2026.189581_bb0685","article-title":"HPV infection and the immune microenvironment in cervical cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"6260","key":"10.1016\/j.bbcan.2026.189581_bb0690","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.aab3291","article-title":"DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway","volume":"350","author":"Lau","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0695","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28310","article-title":"DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation","volume":"95","author":"Lou","year":"2023","journal-title":"J. Med. Virol."},{"issue":"42","key":"10.1016\/j.bbcan.2026.189581_bb0700","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1038\/sj.onc.1202960","article-title":"The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha","volume":"18","author":"Li","year":"1999","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189581_bb0705","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/modpathol.2016.64","article-title":"Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix","volume":"29","author":"Heeren","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2026.189581_bb0710","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fonc.2020.00019","article-title":"Schwann cell-derived CCL2 promotes the perineural invasion of cervical cancer","volume":"10","author":"Huang","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189581_bb0715","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-024-07030-9","article-title":"Cervical cancer-produced neuromedin-B reprograms Schwann cells to initiate perineural invasion","volume":"15","author":"Gao","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189581_bb0720","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/cas.13275","article-title":"\u03b22-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells","volume":"108","author":"Chen","year":"2017","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189581_bb0725","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1158\/2326-6066.CIR-18-0833","article-title":"Blockade of \u03b2-adrenergic receptors improves CD8(+) T-cell priming and cancer vaccine efficacy","volume":"7","author":"Daher","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189581_bb0730","first-page":"3437","article-title":"Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients","volume":"12","author":"Han","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0735","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13046-020-01627-6","article-title":"Metformin inhibits cervical cancer cell proliferation by modulating PI3K\/Akt-induced major histocompatibility complex class I-related chain A gene expression","volume":"39","author":"Xia","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189581_bb0740","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3389\/fimmu.2018.01914","article-title":"The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors","volume":"9","author":"Moreno","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189581_bb0745","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s42003-022-04142-w","article-title":"Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer","volume":"5","author":"Li","year":"2022","journal-title":"Commun. Biol."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189581_bb0750","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovi\u0107","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189581_bb0755","article-title":"iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer","volume":"4","author":"Furukawa","year":"2023","journal-title":"Cell. Rep. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189581_bb0760","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189581_bb0765","article-title":"HER2-positive metastatic cervical cancer responsive to first and second-line treatment: a case report","volume":"31","author":"Fortman","year":"2020","journal-title":"Gynecol. Oncol. Rep."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189581_bb0770","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/cncr.28471","article-title":"Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer","volume":"120","author":"Nogueira-Rodrigues","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189581_bb0775","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2060019","article-title":"Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer","volume":"18","author":"Zhu","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"issue":"46","key":"10.1016\/j.bbcan.2026.189581_bb0780","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1038\/s41388-019-0911-6","article-title":"CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8(+) T-cell responses by upregulating MHC-I expression","volume":"38","author":"Westrich","year":"2019","journal-title":"Oncogene"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:37:47Z","timestamp":1780605467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":156,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0304419X26000533"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189581","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor immune microenvironment in cervical cancer: Histological subtype-specific immune landscapes and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189581"}}